The usefulness of serum APM2 as a predictable marker for the response to platinum based antineoplastic drugs.
Not Applicable
- Conditions
- Hepatocellular carcinoma, Gastric cancer, Esophageal cancer
- Registration Number
- JPRN-UMIN000028487
- Lead Sponsor
- Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are considered to be inappropriate candidate for this study by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum APM2 concentration The effect of platinum antineoplastic drugs on the tumors.
- Secondary Outcome Measures
Name Time Method Serum APM2 concentration The side-effects of platinum antineoplastic drugs on the tumors.